Canada cracks down on opioid abuse amid record deaths

13 December 2016
canada-flag-big

The Canadian government has announced new legislation aimed at tackling the growing problem of opioid drug abuse, citing statistics that record numbers of Canadians have died from drug overdoses this year.

The government made particular reference to the abuse of the opioid painkiller fentanyl, the generic ingredient found in 24 branded drugs. Fentanyl has a similar mechanism of action to morphine, but is between 50 and 100 times more potent.

Statistics in September revealed deaths from fentanyl in Canada rose 61.6% on the same period last year to 488 in a single state, British Columbia. The drug most frequently finds its way into the country from China.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical